Search research articles
Contact Us
Filters
Showing results (321-330 of 330) with videos related to
Page
of 33
Sort By:
You have reached the last page of results.
This site can display upto 330 results.
British Journal of Cancer
|
December 10, 1999
Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan
C Nagata, H Shimizu, H Yoshikawa, et al.
Genes, Chromosomes & Cancer
|
August 26, 1998
Identification of a 100-kb region of common allelic loss on chromosome bands 10q25-q26 in human endometrial cancer
H Yamakawa, S Nagase, M Yuki, et al.
The Tohoku Journal of Experimental Medicine
|
October 1, 1980
Combination chemotherapy in advanced ovarian cancer
A Yajima, H Higashiiwai, A Sato, et al.
The Journal of Infection
|
September 1, 1999
Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo
N Yaegashi, T Niinuma, H Chisaka, et al.
Oncology Reports
|
February 22, 2001
Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer
K Yamamoto, K Noda, M Hatae, et al.
Oncology
|
January 25, 2000
Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer
T Sugiyama, M Yakushiji, K Noda, et al.
The Journal of Obstetrics and Gynaecology Research
|
June 1, 1997
The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group
N Terakawa, J Kigawa, Y Taketani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 8, 1998
[Effect of 5'-DFUR used concurrently in radiotherapy and immunotherapy uterine cervical cancer--pilot study. Study of 5'-DFUR for Uterine Cervical Cancer]
M Hatae, K Noda, A Yajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 5, 1998
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group]
K Noda, K Tanaka, M Ozaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 1, 1996
[Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion]
K Noda, M Ikeda, R Kudo, et al.
Page
of 33
Search research articles
Search
Showing results (321-330 of 330) with videos related to
Sort By:
Page
of 33
You have reached the last page of results.
This site can display upto 330 results.
British Journal of Cancer
|
December 10, 1999
Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan
C Nagata, H Shimizu, H Yoshikawa, et al.
Genes, Chromosomes & Cancer
|
August 26, 1998
Identification of a 100-kb region of common allelic loss on chromosome bands 10q25-q26 in human endometrial cancer
H Yamakawa, S Nagase, M Yuki, et al.
The Tohoku Journal of Experimental Medicine
|
October 1, 1980
Combination chemotherapy in advanced ovarian cancer
A Yajima, H Higashiiwai, A Sato, et al.
The Journal of Infection
|
September 1, 1999
Parvovirus B19 infection induces apoptosis of erythroid cells in vitro and in vivo
N Yaegashi, T Niinuma, H Chisaka, et al.
Oncology Reports
|
February 22, 2001
Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer
K Yamamoto, K Noda, M Hatae, et al.
Oncology
|
January 25, 2000
Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer
T Sugiyama, M Yakushiji, K Noda, et al.
The Journal of Obstetrics and Gynaecology Research
|
June 1, 1997
The behavior of endometrial hyperplasia: a prospective study. Endometrial Hyperplasia Study Group
N Terakawa, J Kigawa, Y Taketani, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
May 8, 1998
[Effect of 5'-DFUR used concurrently in radiotherapy and immunotherapy uterine cervical cancer--pilot study. Study of 5'-DFUR for Uterine Cervical Cancer]
M Hatae, K Noda, A Yajima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 5, 1998
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group]
K Noda, K Tanaka, M Ozaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 1, 1996
[Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion]
K Noda, M Ikeda, R Kudo, et al.
Page
of 33